E040: Caspar Barnes: Improving Donor Diversity Using Blockchain Technology
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
A proposito di questo titolo
Why does the current biomedical research system primarily favour Caucasian individuals?
This week I am joined by Casper Barnes, the founder and CEO of AminoChain. He's actively working on rectifying this inequality through the creation of a blockchain-based platform that enables donors to monitor their samples and earn a share of the proceeds when they are utilised for commercial purposes. This will help to incentivise participation in research from a wider range of people, and ensure that donors are fairly compensated for their contributions.
Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/
Twitter: https://twitter.com/livialifes
LinkedIn: http://www.linkedin.com/in/livialifes G
uests: https://www.linkedin.com/in/caspar-barnes-647645155/
#CEO #Podcast #BiomedicalResearch #DiversityInResearch #BlockchainTechnology #InnovationInHealthcare #FairCompensation